To determine which of the deregulated m6A modified transcripts could be direct targets of METTL3, we assessed the transcriptome-wide mRNAs with m6A in the shCon and shMETTL3 ccRCC cells. The gene discussed is METTL3; the disease is nonpapillary renal cell carcinoma.